John Renger serves as Executive at Cerevel Therapeutics Holdings, Inc., where they oversee executive responsibilities. Since joining the company, John Renger has executed 56 insider transactions totaling $16.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 10, 2021 involved selling 2,063 shares valued at $87.4K.
John Renger currently holds 6,370 shares of Cerevel Therapeutics Holdings, Inc. (CERE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Renger has been a net seller of CERE stock. They have purchased $0 and sold $16.1M worth of shares.
John Renger's most recent insider trade was on Nov 10, 2021, when they sold 2,063 shares at $42.37 per share.
Get notified when new Form 4 filings are submitted
| $41.44 |
| Discretionary |
| Nov 10, 2021 | CERE | $405.3K | Sale | 10,030 | $40.41 | Discretionary |
| Nov 10, 2021 | CERE | $243.0K | Sale | 6,135 | $39.61 | Discretionary |
| Nov 10, 2021 | CERE | $912.0K | Sale | 23,632 | $38.59 | Discretionary |
| Nov 10, 2021 | CERE | $192.5K | Option Exercise | 55,000 | $3.50 | Discretionary |